Zhao, J., Qin, L., He, G., Xie, T., Hu, G., Wang, F., . . . Xu, Y. (2023). Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of CD8+ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral cGAS/STING signaling. Cancer Medicine, 12(23), 21293. https://doi.org/10.1002/cam4.6605
Chicago Style (17th ed.) CitationZhao, Junfeng, Le Qin, Guorong He, Tiancheng Xie, Guanghui Hu, Furan Wang, Hongji Zhong, Jianming Zhu, and Yunfei Xu. "Administration of a Glypican‐3 Peptide Increases the Infiltration and Cytotoxicity of CD8+ T Cells Against Testicular Yolk Sac Tumor, Associated with Enhancing the Intratumoral CGAS/STING Signaling." Cancer Medicine 12, no. 23 (2023): 21293. https://doi.org/10.1002/cam4.6605.
MLA (9th ed.) CitationZhao, Junfeng, et al. "Administration of a Glypican‐3 Peptide Increases the Infiltration and Cytotoxicity of CD8+ T Cells Against Testicular Yolk Sac Tumor, Associated with Enhancing the Intratumoral CGAS/STING Signaling." Cancer Medicine, vol. 12, no. 23, 2023, p. 21293, https://doi.org/10.1002/cam4.6605.